drugset / Trial / NCT00298857

A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights

NCT00298857

Phase 4 Terminated 22 enrolled Northwell Health
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the blood levels of valproic acid in subjects with different body weights and to evaluate whether the pharmacokinetic parameters of this drug is altered in the obese population.

Timeline

Start
2006-03
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Valproic Acid Small molecule

Indications